Particle Therapy 2017

Previous Page

Next Page

Page Background

Stage at diagnosis

Stage distribution 5-y relative

survival

Localized (confined to primary site)

22%

37.80%

Regional (spread to regional lymphnodes) 30%

19.80%

Distant (cancer has metastasized)

35%

3.40%

Unknown (unstaged)

13%

10.50%

Staging